Ogle et al. [51] looked at a variety of LMICs and found that the annual median cost for the management of diabetes (insulin, blood glucose meters, test strips, syringes and HbA1c tests) was US$533 (range: US$255 in Pakistan to US$1185 in Burkina Faso). The gene discussed is INS; the disease is diabetes mellitus.